サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1452456

磁性ナノ粒子市場の予測：～2030年

Magnetic Nanoparticles Market Research Report Forecast to 2030
出版日: | 発行: Market Research Future | ページ情報: 英文 104 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
磁性ナノ粒子市場の予測：～2030年
出版日: 2024年03月07日
発行: Market Research Future
ページ情報: 英文 104 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

磁性ナノ粒子は、その特殊な性質により、さまざまな分野で幅広い用途があります。特に、マグネトフェクション、光熱療法、光線力学療法、標的ドラッグデリバリー、磁気温熱療法などの癌治療で多く採用されています。

廃水産業からの磁性ナノ粒子への需要の増加は、米国と中国の磁性ナノ粒子市場に成長機会をもたらすと考えられています。

米国と中国の磁性ナノ粒子市場は、バイオメディカルおよびヘルスケア部門の拡大によって牽引される見通しです。前処理キットのプロセスにおける磁性ナノ粒子技術の利用の増加が米国の磁性ナノ粒子市場を牽引しています。

当レポートでは、世界の磁性ナノ粒子の市場を調査し、市場の定義と概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 市場概要

第2章 市場力学

  • 概要
  • 促進要因
    • 米国におけるバイオメディカルおよびヘルスケア部門の拡大
    • 中国におけるバイオメディカルおよびヘルスケア部門の拡大
    • 前処理キットにおける磁性ナノ粒子技術の使用の増加
  • 抑制要因
    • 中国における磁性ナノ粒子材料の価格変動
    • 米国における磁性ナノ粒子材料の価格変動
    • 磁性ナノ粒子材料の毒性と生体適合性
  • 機会
    • 水処理における磁性ナノ粒子の使用の増加
  • 動向
    • 磁性を利用して目的の病原菌を分離・濃縮できる磁性ナノ粒子のコア技術
    • 磁性ナノ粒子を用いた敗血症のナノ診断技術（MNPS）

第3章 磁性ナノ粒子の官能基とサイズの定性分析

  • 機能グループ別
  • サイズ別
  • バイオ診断に使用される磁気ビーズベースの手法：概要

第4章 競合情勢

  • 競合分析
  • 市場シェア分析
  • 主要な成長戦略（バイオ診断エンドユーザー）
  • 競合ベンチマーキング
  • 開発数でのリーダー企業
  • 主な展開・成長戦略
  • 主要企業の財務データ

第5章 企業プロファイル

  • QIAGEN NV
  • BIONEER CORPORATION
  • T2 BIOSYSTEMS, INC.
  • THERMO FISHER SCIENTIFIC INC.
  • HOFFMANN-LA ROCHE LTD
  • CREATIVE BIOGENE
  • MAGGENOME TECHNOLOGIES PVT. LTD.
  • DAAN GENE CO., LTD.
  • MAGBIO GENOMICS INC.
  • BECKMAN COULTER INC.（DANAHER CORPORATION）
  • XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
  • GUANGZHOU DONGSHENG BIOTECH CO., LTD
  • GENEAID BIOTECH LTD.
  • TIANGEN BIOTECH(BEIJING)CO., LTD.
  • WUXI NEST BIOTECHNOLOGY CO., LTD
図表

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS 15
  • TABLE 2 PRODUCT LAUNCH/PRODUCT DEVELOPMENT 47
  • TABLE 3 PARTNERSHIP/COLLABORATION 48
  • TABLE 4 SALES, OPERATING INCOME, R & D EXPENDITURE 2022 49
  • TABLE 5 QIAGEN N.V.: PRODUCTS OFFERED 52
  • TABLE 6 QIAGEN N. V.: KEY DEVELOPMENTS 53
  • TABLE 7 BIONEER CORPORATION: PRODUCTS OFFERED 56
  • TABLE 8 BIONEER CORPORATION: KEY DEVELOPMENTS 57
  • TABLE 9 T2 BIOSYSTEMS, INC.: PRODUCTS OFFERED 60
  • TABLE 10 T2 BIOSYSTEMS, INC.: KEY DEVELOPMENTS 60
  • TABLE 11 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 64
  • TABLE 12 HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 68
  • TABLE 13 CREATIVE BIOGENE: PRODUCTS OFFERED 71
  • TABLE 14 MAGGENOME TECHNOLOGIES PVT. LTD.: PRODUCTS OFFERED 74
  • TABLE 15 MAGGENOME TECHNOLOGIES PVT. LTD.: KEY DEVELOPMENTS 75
  • TABLE 16 DAAN GENE CO., LTD: PRODUCTS OFFERED 78
  • TABLE 17 MAGBIO GENOMICS INC.: PRODUCTS OFFERED 81
  • TABLE 18 BECKMAN COULTER INC. (DANAHER CORPORATION): PRODUCTS OFFERED 85
  • TABLE 19 BECKMAN COULTER INC. (DANAHER CORPORATION): KEY DEVELOPMENTS 85
  • TABLE 20 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD: PRODUCTS OFFERED 88
  • TABLE 21 GUANGZHOU DONGSHENG BIOTECH CO., LTD: PRODUCTS OFFERED 92
  • TABLE 22 GENEAID BOITECH LTD.: PRODUCTS OFFERED 95
  • TABLE 23 GENEAID BOITECH LTD.: KEY DEVELOPMENTS 95
  • TABLE 24 TIANGEN BIOTECH (BEIJING) CO., LTD.: PRODUCTS OFFERED 99
  • TABLE 25 WUXI NEST BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 102

LIST OF FIGURES

  • FIGURE 1 MAGNETIC NANOPARTICLES MARKET: MARKET STRUCTURE 14
  • FIGURE 2 MARKET DYNAMICS: US AND CHINA MAGNETIC NANOPARTICLES MARKET 16
  • FIGURE 3 MARKET SIZE OF BIOMEDICAL INDUSTRY IN CHINA FROM 2015 TO 2019 (BILLION YUAN) 18
  • FIGURE 4 USE OF MNPS FOR BIOMEDICAL APPLICATIONS 19
  • FIGURE 5 SCHEMATIC PROCEDURE FOR NUCLEIC ACID PURIFICATION BY MEANS OF MAGNETIC NANOPARTICLE (MNPS) 21
  • FIGURE 6 DRIVERS: IMPACT ANALYSIS 22
  • FIGURE 7 PRICES FOR IRON ORE MARKET IN CHINA, 2019-2022, USD PER TONS 23
  • FIGURE 8 PRICES FOR IRON ORE MARKET IN US, 2019-2022, USD PER TONS 25
  • FIGURE 9 RESTRAINT: IMPACT ANALYSIS 27
  • FIGURE 10 RESTRAINT: IMPACT ANALYSIS 28
  • FIGURE 11 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS) 31
  • FIGURE 12 FIGURE A) REPRESENTS SCHEMATIC REPRESENTATION OF T2MR DIAGNOSTIC PLATFORM 32
  • FIGURE 13 FIGURE B) REPRESENTS NANOMAGNETO-DNA ASSAY FOR THE DETECTION OF BACTERIAL 16S RRNA 33
  • FIGURE 14 FIGURE C) REPRESENTS SERS SUBSTRATES TO ANCHOR ANTIBODY-DECORATED 34
  • FIGURE 15 MARKET SHARE ANALYSIS, 2022 43
  • FIGURE 16 COMPETITIVE BENCHMARKING 44
  • FIGURE 17 COMPETITIVE BENCHMARKING 45
  • FIGURE 18 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET (BIO-DIAGNOSTIC COMPANIES) 46
  • FIGURE 19 QIAGEN N. V.: FINANCIAL OVERVIEW SNAPSHOT 51
  • FIGURE 22 T2 BIOSYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT 59
  • FIGURE 24 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 63
  • FIGURE 26 HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 67
  • FIGURE 29 MAGGENOME TECHNOLOGIES PVT. LTD.: SWOT ANALYSIS 75
  • FIGURE 30 DAAN GENE CO., LTD: SWOT ANALYSIS 79
  • FIGURE 32 BECKMAN COULTER INC. (DANAHER CORPORATION): FINANCIAL OVERVIEW SNAPSHOT 84
  • FIGURE 33 BECKMAN COULTER INC. (DANAHER CORPORATION): SWOT ANALYSIS 86
目次

Market Overview

Magnetic nanoparticles define as the use of tiny particles that possess magnetic properties are typically ranging from 1 to 500 nanometres in size. Magnetic Nanoparticles is receptor immobilized magnetic nanoparticles bind specifically to bacteria and viruses. It is a core technology that can separate and concentrate target pathogens through magnetism. After directly synthesizing magnetic nanoparticles, self-coating is performed to prevent aggregation and then, various functional groups possessed are fixed to realize a concentrating effect. These nanoparticles are often composed of magnetic materials such as iron, cobalt, or nickel, or their alloys. They exhibit unique characteristics such as magnetic behavior at the nanoscale, which can be manipulated and controlled for various applications including wastewater treatment, electronics, healthcare sector, biomedical, energy and other application. Magnetic nanoparticles have a wide range of uses in different fields due to their special properties. Most notably, magnetic nanoparticles are frequently employed in cancer treatment methods like magnetofection, photothermal therapy, photodynamic therapy, targeted drug delivery, and magnetic hyperthermia.

However, the fluctuations in the prices of magnetic nanoparticles materials and toxicity and biocompatibility of magnetic nanoparticles materials will likely restrain market growth. On the other hand, to rise in demand for magnetic nanoparticles from wastewater industry will create growth opportunities for the US and China Magnetic Nanoparticles market.

Market Segmentation

The functional group of magnetic particles has been majorly classified into -COOH, -NH2, -SiO2, -Tosyl , and -Streptavidin.

The size range of magnetic particles has been majorly classified into 100, 200, 300, and 500 nm. The size of magnetic particles can greatly impact their magnetic behavior, surface area, stability, and interactions with other molecules or systems.

Regional Analysis

The US and China Magnetic Nanoparticles market is expected to be driven by increasing expansion of biomedical and healthcare sector in US and China. The Increase usage of magnetic nanoparticles technology in process of pretreatment kits are driving the US Magnetic Nanoparticles market.

Major Players

Qiagen N. V., Bioneer Corporation, T2 Biosystems Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Creative Biogene, Baker Coulters Inc. (Danaher Corporation), MagBio Genomics Inc., DaAn Gene Co., Ltd, and MagGenome Technologies Pvt. Ltd among others are the major companies in the Magnetic Nanoparticles Market.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 DEFINITION
  • 1.2 SCOPE OF THE STUDY
  • 1.3 RESEARCH OBJECTIVE
  • 1.4 MARKET STRUCTURE
  • 1.5 LIST OF ASSUMPTIONS

2 MARKET DYNAMICS

  • 2.1 OVERVIEW
  • 2.2 DRIVERS
    • 2.2.1 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN US
    • 2.2.2 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN CHINA
    • 2.2.3 INCREASE USAGE OF MAGNETIC NANOPARTICLES TECHNOLOGY IN PRETREATMENT KITS
  • 2.3 RESTRAINTS
    • 2.3.1 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN CHINA
    • 2.3.2 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN US
    • 2.3.3 TOXICITY AND BIOCOMPATIBILITY OF MAGNETIC NANOPARTICLES MATERIALS
  • 2.4 OPPORTUNITIES
    • 2.4.1 INCREASING USE OF MAGNETIC NANOPARTICLES FOR WATER TREATMENT
  • 2.5 TRENDS
    • 2.5.1 CORE TECHNOLOGY OF MAGNETIC NANOPARTICLES THAT CAN SEPARATE AND CONCENTRATE TARGET PATHOGENS THROUGH MAGNETISM
    • 2.5.2 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS)

3 QUALITATIVE ANALYSIS ON FUNCTIONAL GROUP AND SIZE FOR MAGNETIC NANOPARTICLES

  • 3.1 BY FUNCTIONAL GROUP
  • 3.2 BY SIZE
  • 3.3 OVERVIEW OF MAGNETIC BEAD-BASED METHOD EMPLOYED IN BIO-DIAGNOSTICS

4 COMPETITIVE LANDSCAPE

  • 4.1 INTRODUCTION
  • 4.2 COMPETITIVE ANALYSIS
  • 4.3 MARKET SHARE ANALYSIS
  • 4.4 MAJOR GROWTH STRATEGY IN THE MAGNETIC NANOPARTICES MARKET (BIO-DIAGNOSTIC END USERS)
  • 4.5 COMPETITIVE BENCHMARKING
  • 4.6 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET
  • 4.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 4.7.1 PRODUCT LAUNCH/ PRODUCT DEVELOPMENT
    • 4.7.2 PARTNERSHIP/COLLABORATION
  • 4.8 MAJOR PLAYER FINANCIAL*
    • 4.8.1 SALES, OPERATING INCOME, R&D EXPENDITURE 2022*

5 COMPANY PROFILES

  • 5.1 QIAGEN NV
    • 5.1.1 COMPANY OVERVIEW
    • 5.1.2 FINANCIAL OVERVIEW
    • 5.1.3 PRODUCTS OFFERED
    • 5.1.4 KEY DEVELOPMENTS
    • 5.1.5 SWOT ANALYSIS
    • 5.1.6 KEY STRATEGIES
  • 5.2 BIONEER CORPORATION
    • 5.2.1 COMPANY OVERVIEW
    • 5.2.2 FINANCIAL OVERVIEW
    • 5.2.3 PRODUCTS OFFERED
    • 5.2.4 KEY DEVELOPMENTS
    • 5.2.5 SWOT ANALYSIS
    • 5.2.6 KEY STRATEGIES
  • 5.3 T2 BIOSYSTEMS, INC.
    • 5.3.1 COMPANY OVERVIEW
    • 5.3.2 FINANCIAL OVERVIEW
    • 5.3.3 PRODUCTS OFFERED
    • 5.3.4 KEY DEVELOPMENTS
    • 5.3.5 SWOT ANALYSIS
    • 5.3.6 KEY STRATEGIES
  • 5.4 THERMO FISHER SCIENTIFIC INC.
    • 5.4.1 COMPANY OVERVIEW
    • 5.4.2 FINANCIAL OVERVIEW
    • 5.4.3 PRODUCTS OFFERED
    • 5.4.4 KEY DEVELOPMENTS
    • 5.4.5 SWOT ANALYSIS
    • 5.4.6 KEY STRATEGIES
  • 5.5 HOFFMANN-LA ROCHE LTD
    • 5.5.1 FINANCIAL OVERVIEW
    • 5.5.2 PRODUCTS OFFERED
    • 5.5.3 KEY DEVELOPMENTS
    • 5.5.4 SWOT ANALYSIS
    • 5.5.5 KEY STRATEGIES
  • 5.6 CREATIVE BIOGENE
    • 5.6.1 COMPANY OVERVIEW
    • 5.6.2 FINANCIAL OVERVIEW
    • 5.6.3 PRODUCTS OFFERED
    • 5.6.4 KEY DEVELOPMENTS
    • 5.6.5 SWOT ANALYSIS
    • 5.6.6 KEY STRATEGIES
  • 5.7 MAGGENOME TECHNOLOGIES PVT. LTD.
    • 5.7.1 COMPANY OVERVIEW
    • 5.7.2 FINANCIAL OVERVIEW
    • 5.7.3 PRODUCTS OFFERED
    • 5.7.4 KEY DEVELOPMENTS
    • 5.7.5 SWOT ANALYSIS
    • 5.7.6 KEY STRATEGIES
  • 5.8 DAAN GENE CO., LTD.
    • 5.8.1 COMPANY OVERVIEW
    • 5.8.2 FINANCIAL OVERVIEW
    • 5.8.3 PRODUCTS OFFERED
    • 5.8.4 KEY DEVELOPMENTS
    • 5.8.5 SWOT ANALYSIS
    • 5.8.6 KEY STRATEGIES
  • 5.9 MAGBIO GENOMICS INC.
    • 5.9.1 COMPANY OVERVIEW
    • 5.9.2 FINANCIAL OVERVIEW
    • 5.9.3 PRODUCTS OFFERED
    • 5.9.4 KEY DEVELOPMENTS
    • 5.9.5 SWOT ANALYSIS
    • 5.9.6 KEY STRATEGIES
  • 5.10 BECKMAN COULTER INC. (DANAHER CORPORATION)
  • 5.10. COMPANY OVERVIEW
  • 5.10. FINANCIAL OVERVIEW
  • 5.10. PRODUCTS OFFERED

5.10.4KEY DEVELOPMENTS

5.10.5SWOT ANALYSIS

5.10.6KEY STRATEGIES

  • 5.11 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD

5.11.1COMPANY OVERVIEW

5.11.2FINANCIAL OVERVIEW

5.11.3PRODUCTS OFFERED

5.11.4KEY DEVELOPMENTS

5.11.5SWOT ANALYSIS

5.11.6KEY STRATEGIES

  • 5.12 GUANGZHOU DONGSHENG BIOTECH CO., LTD

5.12.1COMPANY OVERVIEW

5.12.2FINANCIAL OVERVIEW

5.12.3PRODUCTS OFFERED

5.12.4KEY DEVELOPMENTS

5.12.5SWOT ANALYSIS

5.12.6KEY STRATEGIES

  • 5.13 GENEAID BIOTECH LTD.

5.13.1COMPANY OVERVIEW

5.13.2FINANCIAL OVERVIEW

5.13.3PRODUCTS OFFERED

5.13.4KEY DEVELOPMENTS

5.13.5SWOT ANALYSIS

5.13.6KEY STRATEGIES

  • 5.14 TIANGEN BIOTECH(BEIJING)CO., LTD.98

5.14.1COMPANY OVERVIEW

5.14.2FINANCIAL OVERVIEW

5.14.3PRODUCTS OFFERED

5.14.4KEY DEVELOPMENTS

5.14.5SWOT ANALYSIS

5.14.6KEY STRATEGIES

  • 5.15 WUXI NEST BIOTECHNOLOGY CO., LTD

5.15.1COMPANY OVERVIEW

5.15.2FINANCIAL OVERVIEW

5.15.3PRODUCTS OFFERED

5.15.4KEY DEVELOPMENTS

5.15.5SWOT ANALYSIS

5.15.6KEY STRATEGIES